Holding(s) in Company
Icahn School of Medicine at Mount Sinai has reported a change in its voting rights in Trellus Health plc, with its holding decreasing from 22.3% to 17.9%, representing 40,384,897 voting rights. This change is attributed solely to the issuance of new shares following the conversion of a portion of the principal amount outstanding under the second tranche of secured convertible loan notes, rather than any disposal of shares by Icahn School of Medicine at Mount Sinai. Mount Sinai Health System, Inc., as the sole member of Icahn School of Medicine at Mount Sinai, may be deemed to beneficially own these securities.
Select text to share a quote on X · sign in to keep highlights & notes in your TRLS notes
Non-UK issuer
- Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments
| An event changing the breakdown of voting rights | X |
Other (please specify) iii :
Details of person subject to the notification obligation iv
| Name | Icahn School of Medicine at Mount Sinai |
| City and country of registered office (if applicable) | New York, United States |
Full name of shareholder(s) (if different from 3.) v
Name
City and country of registered office (if applicable)
| 5. Date on which the threshold was crossed or reached vi : | 05/03/2026 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 05/03/2026 |
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 17.9% | NA | 17.9% | 40,384,897 |
| Position of previous notification (if applicable) | 22.3% | NA | 22.3% | |
| A: Voting rights attached to shares | ||||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | ||
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) | |
| GB00BNNFM402 | 40,384,897 | 17.9% | ||
SUBTOTAL 8. A
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
SUBTOTAL 8.B.2
| Mount Sinai Health System, Inc. | 17.9% | N/A | 17.9% |
| Icahn School of Medicine at Mount Sinai | 17.9% | N/A | 17.9% |
In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Additional information xvi
Icahn School of Medicine at Mount Sinai has not disposed of any shares. The change in percentage holding is solely due to the issuance of new shares following the conversion of a portion of the principal amount outstanding under the second tranche of the secured convertible loan notes. As the sole member of Icahn School of Medicine at Mount Sinai ("ISMMS"), Mount Sinai Health System, Inc. may be deemed to beneficially own the securities held by ISMMS.
| Place of completion | US |
| Date of completion | 06/03/2026 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.